We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RDPTF market cap is 135.54M. The company's latest EPS is AUD -0.1061 and P/E is -0.19.
| Year End June 29 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 0 | 9k | 6.21M | 1.96M |
| Operating Income | -484k | -19.92M | -33.81M | -45.67M |
| Net Income | -485k | -30.42M | -34.61M | -47.95M |
| Year End June 29 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 33k | 83.38M | 74.95M | 72.04M |
| Total Liabilities | 158k | 20.42M | 29.37M | 44.68M |
| Total Equity | -125k | 62.96M | 45.58M | 27.35M |
| Year End June 29 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -33k | -9.91M | -23.2M | -22.98M |
| Investing | N/A | -28.38M | -1.53M | N/A |
| Financing | 60k | 65.11M | 9.22M | 29.88M |
| Market Cap | 135.54M |
| Price to Earnings Ratio | -0.19 |
| Price to Sales Ratio | 4.65 |
| Price to Cash Ratio | 0.49 |
| Price to Book Ratio | 0.33 |
| Dividend Yield | - |
| Shares Outstanding | 451.8M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 5k |
| 52 Week Change | 252.94% |
| 52 Week High | 0.30 |
| 52 Week Low | 0.0008 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Radiopharm Theranostics Ltd (PK) |
| Address |
level 3 melbourne, victoria 3053 |
| Website | https://www.radiopharmtheranostics.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
